Pulmonary hypertension treatment cost in Italy typically includes essential diagnostics like a consultation with a cardiologist ranging from $100 to $300 and innovative procedures such as pulmonary hypertension stem cell treatment, which runs from $30,000 to $50,000. Total expenses depend on the clinical stage, pharmacological needs, and surgical requirements. Patients often find 40-60% savings compared to the US. Top cities for specialized care include Milan, Rome, and Bologna.
Typical Pulmonary Hypertension Treatment Costs in Italy
Bookimed Expert Insight: Patients with complex cardiological involvement should prioritize IRCCS-accredited centers like San Donato Hospital in Milan. This facility performs over 9,400 cardiovascular operations annually, offering the highest surgical volume in Italy. For those seeking cutting-edge therapies, San Raffaele provides world-first stem cell protocols and specialized research. Maria Cecilia Hospital is best for multidisciplinary "Heart Team" approaches, handling over 15% of the country's cardiac surgeries.
| Italy | Turkey | Austria | |
| Pulmonary hypertension stem cell treatment | from $30,000 | from $12,000 | from $55,000 |
| LDL Apheresis | from $1,650 | from $1,650 | - |
Prof. Savini specializes in Minimally Invasive Surgery for pulmonary hypertension, with experience at top European cardiology institutions.
Prof Giuseppe Speziale specializes in minimally invasive cardiac surgery, with a focus on pulmonary hypertension. He leads cardiac surgery departments at multiple prestigious hospitals and co-founded the Mitral Academy.
The doctor specializes in Cardiology and Cardiovascular Surgery, focusing on minimally invasive and noninvasive valvular surgeries. With a distinguished career, the doctor has contributed significantly to the field through research, publications, and active participation in professional organizations.
Graduating with honors from the Catholic University of the Sacred Heart Rome, the doctor further specialized in Cardiac Surgery at La Sapienza University. Currently, the doctor serves as the Director of Cardiac Surgery at Santa Maria Hospital and Anthea Hospital, and is the Vice President of GVM Care & Research.
The doctor has a distinguished career in vascular surgery, transitioning from cardiac surgery to focus on thoracic and thoracoabdominal aortic diseases and vascular graft infections. Notable contributions include the 'frozen elephant trunk' technique and advancements in branched and fenestrated thoracoabdominal aortic stent grafts. The doctor is actively involved in research and holds memberships in prestigious vascular surgery societies. Educational background includes a degree from Milan University and specializations in general, vascular, and cardiac surgery.